Synthetic, engineered, targeted vaccines: Selecta ... - Examiner

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service18 times read : Adjust font size: Decrease font Enlarge font
image

Jeff Hubbell and colleagues at the EPFL in Lausanne, Switzerland (2) have been investigating development of tiny nanoparticles which bypass the skin’s immune response after subcutaneous injection and travel directly to the lymph nodes and it’s ...

Read this article...



Post your comment comment Comments (0 posted)

copyright